Partners
JCOIN Equity, Diversity, and Inclusion (EDI) Speaker Series
Advancing Health Equity: Conducting Addiction Research with Racial/Ethnic Minoritized Populations Dr. LaTrice Montgomery, a Research Associate Professor and Licensed Clinical Psychologists at the University of Cincinnati College of Medicine, will discuss the importance of conducting addiction research with racial and ethnic minoritized populations. Dr. Montgomery will provide strategies for conducting effective research with populations that…
Read MoreBudget Impact Tool to Help Estimate Costs of Providing Medications to Treat Opioid Use Disorder in Jails/Prisons
Join us on June 9, 2023, at 11:30 a.m. Eastern for a webinar that will discuss the budget impact tool, how it works, and how it can be utilized by practitioners who work in correctional settings. To register for the webinar, click here. Register for the webinar Despite the evidence that providing medications for opioid…
Read MoreHHS Releases New Medicaid Reentry 1115 Demonstration Opportunity to Increase Access to Care for Individuals Leaving Prison and Jail
On April 17, 2023, the Department of Health and Human Services (HHS), through the Centers for Medicare & Medicaid Services (CMS), released new guidance that allows states to utilize Medicaid funds to provide health care services to incarcerated individuals, including substance use disorder treatment. The new Medicaid Reentry Section 1115 Demonstration Opportunity would provide states…
Read MoreSupporting women in the carceral system: Working with community partners to best understand the needs of JCOIN study populations
The University of Kentucky Clinical Research Center (Kentucky Hub) of the NIH/NIDA-funded Justice Community Opioid Innovation Network (JCOIN) is the only Hub nationally to focus exclusively on women. The overall aim of the project is to increase access to medications to treat opioid use disorder (MOUD) among justice-involved women through telehealth linkages with community providers…
Read MoreTreating Opioid Use Disorder in Patients Who Are Incarcerated – Quandaries of a Hospitalist
Download the article (PDF) “Mr J is a man in his early 40s with severe opioid use disorder (OUD) who was incarcerated in a county jail shortly before being brought to the hospital for an injection-related infection. As is common for persons who are hospitalized while incarcerated, he was shackled to the bed with guards…
Read MoreJCOIN Holds In-person Steering Committee Meeting
For the first time since 2019, over 100 researchers and practitioners from the Justice Opioid Innovation Network (JCOIN, NIDA U2CDA050097, PI: Faye Taxman, Ph.D.) gathered in-person to reconnect, celebrate wins, share updates, and further build the community of practice. In addition to members of the JCOIN Steering Committee and the National Institute on Drug Abuse,…
Read MoreJCOIN Webinar | Approaches to Housing People Living with Substance Use Disorders
Home > Partners JCOIN Webinar | Approaches to Housing People Living with Substance Use Disorders Harm Reduction and Implications for Justice-Involved Residents Register Now Thursday, October 6 | 1:30 – 3 p.m. ET In this webinar, Dr. Dennis Watson of Chestnut Health Systems will walk the audience through a description of the Housing First…
Read MoreStudy Identifies Key Barriers and Facilitators for Medications to Treat Opioid Use Disorders in U.S. Jails
Download the Fact Sheet (PDF) Findings from JCOIN’s Chestnut Health Systems Clinical Research Center Transitioning to the community following incarceration is a particularly high risk for individuals with opioid use disorder (OUD), especially during the first two weeks of release. Substantial evidence shows that initiating medications for opioid use disorder (MOUD) during incarceration and continuation…
Read MoreAmerica’s Opioid Ecosystem
Opioids play an outsized role in America’s drug problems, but they also play a critically important role in medicine. Thus, they deserve special attention. Illegally manufactured opioids (such as fentanyl) are involved in a majority of U.S. drug overdoses, but the problems are broader and deeper than drug fatalities. Depending on the drugs involved, there…
Read MoreWebinar: Treatment Considerations in the Age of Fentanyl
Register Now Wednesday, April 5, 2023 | 12–1:30 p.m. ET Fentanyl and other high potency synthetic opioids are increasingly present in the U.S. drug supply. Healthcare systems, treatment providers and justice systems are grappling with the physiological consequences of chronic fentanyl use and how its use may impact treatment. Presenters will discuss practical clinical…
Read More